The U.S. Food and Drug Administration has published safety labeling changes made prescribing information for 32 products in July.
Changes were made to boxed warnings, contraindications, warnings, precautions, adverse reactions, patient package insert and medication guide.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
The following drugs had modifications to the boxed warnings, contraindications and warnings sections:
Epogen/Procrit (epoetin alfa) and Aranesp (darbepoetin alfa)
Dostinex (cabergoline) Tablets
Nitrostat (nitroglycerin, USP) Sublingual Tablets
Paxil (paroxetine HCl) tablets, oral solution and Paxil CR tablets
Ranexa (Ranolazine) Extended-Release Tablets
Rotavirus Vaccine, Live, Oral, Pentavalent (RotaTeq)
Arava (leflunomide) Tablets
Bentyl (dicyclomine hydrochloride, USP) Capsules/Tablets, Oral Syrup, Injection
Chantix (varenicline) Tablets
Flomax (tamsulosin hydrochloride) Capsules
Gilenya (fingolimod) capsules 0.5 mg
Kenalog-10 (triamcinolone acetonide) Injection, Kenalog-40 (triamcinolone acetonide) Injection
Micardis (telmisartan) Tablets
Prograf (tacrolimus) Capsules, Injection
Seroquel (quetiapine fumarate) Tablets, Seroquel (quetiapine fumarate) XR
Tev-Tropin (somatropin [rDNA origin]) for injection
Truvada (emtricitabine/tenofovir disoproxil fumarate) tablets
Zegerid OTC (omeprazole 20mg and sodium bicarbonate 1100 mg) capsules
To view a listing of drug names and safety labeling sections revised, click here. Clicking on a drug product name in the Summary View will take you to the "detailed view" page, which identifies safety labeling sections and subsections revised, along with a brief summary of new or modified safety information.
Related Articles on Medication Safety:
Staff Education Tool: 'Do Not Crush' List (Oral Dosage Forms That Should Not be Crushed)
Patient Safety Tool: Spanish Language Medication Tracking Tool